PUMA BIOTECHNOLOGY, INC.

PBYI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
144 Jun 13, 2024
144 Jun 13, 2024
144 Jun 13, 2024
144 Jun 13, 2024
8-K May 17, 2024 FORM 8-K
10-Q May 2, 2024 FORM 10-Q
8-K May 2, 2024 FORM 8-K
DEFA14A Apr 26, 2024 FORM DEFA14A
ARS Apr 26, 2024
DEF 14A Apr 26, 2024 FORM DEF 14A
SC 13G Mar 29, 2024 SC 13G
4 Mar 19, 2024 FORM 4
8-K Mar 19, 2024 FORM 8-K
10-K Feb 29, 2024 FORM 10-K
8-K Feb 29, 2024 FORM 8-K
4 Feb 14, 2024 FORM 4
4 Feb 14, 2024 FORM 4
4 Feb 14, 2024 FORM 4
4 Feb 14, 2024 FORM 4
4 Feb 14, 2024 FORM 4
SC 13G/A Feb 14, 2024 PRIMARY DOCUMENT
SC 13G/A Feb 13, 2024 SCHEDULE 13G/A
SC 13G/A Feb 6, 2024 PUMA BIOTECHNOLOGY, INC.
SC 13G/A Jan 30, 2024
8-K Jan 18, 2024 FORM 8-K
← Newer Page 7 of 45 · 1117 filings Older →